Walleye Capital
EPIX

Walleye Capital’s ESSA Pharma EPIX Stock Holding History

Walleye Capital’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20,784
Closed -$52.4K – 4036
2022
Q4 		$52.4K Sell
20,784
-216,369
-91% -$621K ﹤0.01% 2514
2022
Q3 		$432K Buy
237,153
+132,760
+127% +$350K 0.01% 1571
2022
Q2 		$329K Buy
104,393
+45,004
+76% +$251K 0.01% 1258
2022
Q1 		$367K Buy
+59,389
New +$522K 0.01% 1190
2021
Q4 		– Sell
-113,444
Closed -$908K – 2160
2021
Q3 		$908K Buy
+113,444
New +$1.8M 0.03% 494

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Walleye Capital's EPIX Position: Q1 2023 in Review

Walleye Capital sold out of ESSA Pharma (EPIX) in Q1 2023, closing a stake of 20,784 shares — an estimated $52.4K sold.

Walleye Capital first reported a position in EPIX in Q3 2021 and held it in 5 quarters. The position peaked at $908K in Q3 2021. 37 funds tracked by Wall St. Rank hold EPIX as of Q1 2023.

  • Walleye Capital reported no remaining ESSA Pharma position as of Q1 2023 after selling out during the quarter.
  • Walleye Capital sold 20,784 ESSA Pharma shares in Q1 2023, an estimated $52.4K.
  • Walleye Capital first reported a position in ESSA Pharma in Q3 2021 and held it in 5 quarters.
  • Walleye Capital's ESSA Pharma position peaked at $908K in Q3 2021.
  • 37 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.